3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Diabetes -

Drug protects kidneys of people with diabetes

DiabetesSep 10, 05

Kidney damage is a constant danger for people with Diabetes Mellitus, especially when their blood pressure is high. Now European researchers report that the addition of a drug, spironolactone, to standard blood pressure-lowering therapy for such patients helps reduce both blood pressure and the amount of albumin protein in urine, a measure of kidney impairment.

Dr. Kaspar Rossing of Steno Diabetes Mellitus Center in Gentofte, Denmark, and colleagues note in the medical journal Diabetes Care that two types of antihypertensive drugs—ACE inhibitors and angiotensin receptor blockers (ARBs)—have protective effects on the kidneys in diabetics who already have kidney damage.

These drugs work by controlling the release of a hormone called aldosterone. While they’re effective initially, aldosterone levels may subsequently rise once more in almost 40 percent of patients, resulting in greater urinary protein levels and a faster decline in kidney function.

To see whether supplementary treatment with spironolactone, which is an aldosterone inhibitor, might be helpful in these circumstances, the researchers conducted a study with 21 patients with Type 2 Diabetes Mellitus.

While the participants continued on their recommended antihypertensive treatments (which included diuretics, ACE inhibitors and ARBs), they were randomly assigned to take in addition either an inactive placebo or spironolactone for 8 weeks. They then switched to the other pill for another 8 weeks.

During spironolactone treatment, urinary albumin levels fell by 33 percent, and their upper and lower blood pressure readings fell by 6 and 4 points.

One patient developed dangerously lower potassium levels and had to be withdrawn from the study, but recovered rapidly. Otherwise, the treatment was well tolerated.

The researchers call for further studies, but conclude that in the short term, spironolactone may offer beneficial renal and cardiovascular protection.

SOURCE: Diabetes Care, September 2005.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar
  Joslin researchers find drugs are effective for diabetic macular edema in new trial
  New superfoods could help key protein keep bodies healthy
  Poor quality of life may affect teens’ diabetes management
  Cancer drug protects against diabetes
  Amino acid’s increase is suspected in diabetes
  New Type 2 Diabetes Drug Onglyza Approved
  Mail order pharmacy use safe for people with diabetes
  Policy considerations pose options for leaders to reduce costly disparities in diabetes
  Cedars-Sinai study sheds light on bone marrow stem cell therapy for pancreatic recovery
  Obesity-Linked Diabetes in Children Resists Treatment
  Diabetes again linked to colon cancer risk

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site